September 17, 2012 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
Austin Medical Design's Cath Cube is a single-use product for management of guidewires and catheters (balloons and ...
September 6, 2012 — Drug-eluting stents (DES) are used less often in women treated with percutaneous coronary ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
August 22, 2012 — Placement of an endovascular stent has become a common procedure for successfully reopening blocked ...
August 20, 2012 — Abbott today announced that the Xience Xpedition everolimus-eluting coronary stent system received CE ...
August 15, 2012 — Previously unreleased three-year data from the Zilver PTX randomized controlled trial of paclitaxel ...
August 14, 2012 — The U.S. Food and Drug Administration (FDA) is hosting a public workshop that examines use of ...
August 9, 2012 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers and patients that the ...
Aug. 8, 2012 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s Omnilink Elite Vascular Balloon ...
July 17, 2012 — Arterial Remodeling Technologies (ART) reported that they have achieved a medical milestone with its ...
As the average age of the U.S. population and the number of patients at high risk for cardiovascular disease ...
July 16, 2012 — Reva Medical Inc. announced it completed clinical enrollment with the ReZolve drug-eluting bioresorbable ...
July 12, 2012 — Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation, a U.S ...
July 3, 2012 — Flexible Stenting Solutions Inc., a leading developer of next generation peripheral arterial, venous ...
June 21, 2012 — Plans for a new study involving BioFreedom, the polymer-free drug-coated stent (DCS) from Biosensors ...